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Insulator elements affect gene expression by
preventing the spread of heterochromatin and
restricting transcriptional enhancers from acti-
vation of unrelated promoters. In vertebrates,
insulator’s function requires association with
the CCCTC-binding factor (CTCF), a protein
that recognizes long and diverse nucleotide
sequences. While insulators are critical in
gene regulation, only a few have been reported.
Here, we describe 13,804 CTCF-binding sites in
potential insulators of the human genome, dis-
covered experimentally in primary human fibro-
blasts. Most of these sequences are located far
from the transcriptional start sites, with their dis-
tribution strongly correlated with genes. The
majority of them fit to a consensus motif highly
conserved and suitable for predicting possible
insulators driven by CTCF in other vertebrate
genomes. In addition, CTCF localization is
largely invariant across different cell types. Our
results provide a resource for investigating insu-
lator function and possible other general and
evolutionarily conserved activities of CTCF
sites.
INTRODUCTION
CTCF plays a critical role in transcriptional regulation in
vertebrates (for reviews, see Ohlsson et al., 2001; Klenova
et al., 2002; Dunn and Davie, 2003). It was first identified
by its ability to bind to a number of dissimilar regulatory se-
quences in the promoter-proximal regions of the chicken,
mouse, and human MYC oncogenes (Filippova et al.,1996; Lobanenkov et al., 1990). CTCF is a ubiquitously ex-
pressed nuclear protein with 11-zinc finger (ZF) DNA-
binding domain (Filippova et al., 1996; Klenova et al.,
1993). It is essential (Fedoriw et al., 2004) and highly con-
served from Drosophila to mice and man (Moon et al.,
2005). Point mutations at the distinct DNA-recognition
amino acid positions in ZF3 and ZF7 of CTCF have been
identified in a variety of cancers selected for LOH at
16q22where CTCFmaps, suggesting its role as candidate
tumor-suppressor gene (Filippova et al., 1998, 2002).
Initial biochemical analyses revealed that CTCF con-
tains two transcription repressor domains and can act as
a transcriptional repressor (Baniahmad et al., 1990; Burcin
et al., 1997; Klenova et al., 1993; Lobanenkov et al., 1990).
However, others have found that it could also function as
a transcriptional activator in a different sequence context
(Vostrov and Quitschke, 1997). Recent studies have iden-
tifiedCTCF tobe the vertebrate insulator protein (Bell et al.,
1999). So far, CTCF remains as the only major protein
implicated in establishment of insulators in vertebrates
(Felsenfeld et al., 2004), including those involved in regula-
tion of gene imprinting and monoallelic gene expression
(Fedoriw et al., 2004; Ling et al., 2006), as well as in X chro-
mosome inactivation and in the escape fromX-linked inac-
tivation (Filippova et al., 2005; Lee, 2003).
There has been a great interest in identifying where po-
tential insulators are located in the eukaryotic genome be-
cause knowledge of these elements can help understand
how cis-regulatory elements coordinate expression of the
target genes. Transcription of every eukaryotic gene be-
gins with the assembly of an RNA polymerase preinitiation
complex (PIC) at the promoter (Kadonaga, 2004), a pro-
cess that is regulated by sequence-specific transcription
factors and cis-regulatory elements. Genetics studies in
Drosophila first identified the importance of insulators in
ensuring proper enhancer/promoter interactions (Udvardy
et al., 1985). More recent studies have implicated insula-
tors in the establishment of euchromatin/heterochromatinCell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc. 1231
boundaries in vertebrates (Felsenfeld et al., 2004; Gerasi-
mova and Corces, 2001; Jeong and Pfeifer, 2004). In addi-
tion, it hasbeendemonstrated that an insulator in the IGF2/
H19 locus is critical for the imprinting of the locus (Bell and
Felsenfeld, 2000; Hark et al., 2000; Kanduri et al., 2000).
The mechanism of insulator function remains unclear.
One model proposes that insulators, by formation of spe-
cial chromatin structures, compete for enhancer-bound
activators, preventing the activation of downstream pro-
moters (Bulger and Groudine, 1999). Alternatively, insula-
tors may facilitate the formation of loops, for example, via
attachment of chromosomal regions to the nuclear mem-
brane (Yusufzai et al., 2004), keeping the intermediate re-
gions exposed for only local interactions between en-
hancers and promoters. Consistent with this model, it
was recently shown that CTCF could mediate long-range
chromosomal interactions in mammalian cells, providing
a possible mechanism by which insulators establish regu-
latory domains (Kurukuti et al., 2006; Ling et al., 2006;
Yusufzai et al., 2004). The extent at which each mecha-
nism plays a role in shaping genome expression remains
unresolved. Knowledge of insulators in the genome would
provide a much-needed framework for understanding the
genome organization and function.
The effort to computationally identify potential insula-
tors in the human genome has been hampered by an
incomplete understanding of the DNA-recognition se-
quence of CTCF. Biochemical assays have indicated
that the 11-ZF protein can use different combinations of
the ZF domains to bind different DNA target sequences
(Filippova et al., 1996; Ohlsson et al., 2001). Thus, the
CTCF-binding sites identified from in vitro protein/DNA-
interaction assays and a limited number of known in-
sulators exhibit extensive sequence variation and lack
specificity for genome-wide prediction of CTCF binding
(Ohlsson et al., 2001). Recently, an attempt has been
made to systematically isolate insulators in the mouse
genome through chromatin immunoprecipitation followed
by cloning and sequencing (Mukhopadhyay et al., 2004).
Unfortunately, due to a limited scale of the sequencing
effort, only about 200 DNA fragments with the enhancer-
blocking activity, each driven by various CTCF-binding
sites, have been identified. However, no consensus of
CTCF-binding motif has been so far reported from this
study.
As a first step toward understanding how insulators
contribute to gene expression in human cells, we have lo-
cated the sites of CTCF binding in the human genome us-
ing chromatin immunoprecipitation followed by detection
with genome-tilingmicroarrays (Kim et al., 2005b; Kim and
Ren, 2006). Our analyses have generated a high-resolu-
tion genomic map of CTCF binding, with on average 2.5
genes bounded by a pair of CTCF-binding sites. We also
identify a clear consensus of CTCF-binding motif shared
by a majority of the experimentally determined in vivo
CTCF-binding sites. We show that the sites of CTCF-bind-
ing sequences in the human genome are highly conserved
in other vertebrates, consistent with the widespread and1232 Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Incfundamental role of CTCF in cellular function. In addition,
we demonstrate that CTCF binding to DNA is largely in-
variant from cell to cell, with a subset interacting with the
protein in a cell-type-dependent manner. Our results offer
a general resource for understanding the role of CTCF in
insulator function, gene regulation, and genome organiza-
tion in human cells.
RESULTS
Genome-Wide Mapping of CTCF-Binding Sites
Previously, we developed an improved genome-wide lo-
cation-analysis strategy to identify transcription-factor-
binding sites throughout the genome in human cells (Kim
et al., 2005b). This method, also known as ChIP-chip, in-
volved the immunoprecipitation of transcription-factor-
bound DNA from formaldehyde-crosslinked cells, fol-
lowed by detection with genome-tiling arrays. To identify
CTCF-binding sites in the human genome, we performed
the same analysis with monoclonal antibodies against
CTCF and chromatin extract from the primary human fi-
broblast, IMR90, cells. The CTCF-bound DNA was identi-
fied using a series of 38 arrays containing a total of 14.6
million 50-mer oligonucleotides, evenly positioned every
100 base pairs (bp) along the nonrepeat sequence of the
human genome. By applying a simple statistical filtering
that requires the signals from four consecutive probes to
be above a threshold (2.5 times the standard deviation
of the average log ratios), we identified an initial list of
15,221 genomic regions bound by CTCF (Figures 1A and
1B). To verify the binding of CTCF to these putative
CTCF-binding sequences, we designed a new oligonuce-
lotide microarray representing these regions and the sur-
rounding sequences at 100 bp resolution. Using this array,
we performed ChIP-chip analysis against CTCF with an
independent chromatin sample of IMR90 cells and con-
firmed its binding to 13,804 regions.
To assess the accuracy of these in vivo CTCF-binding
sites, we first randomly selected 84 (Table S1) and per-
formed conventional ChIP assays. This analysis validated
the binding of CTCF to 80 (95%) tested sites (Figure S2A)
and suggested a high degree of specificity of our method.
Next, we examined CTCF binding on 60 previously
characterized CTCF-binding sites and insulators in the hu-
man genome and found that 32 (53%) were detected by
our analysis (Table S2). To determinewhether the failure to
detect CTCF binding at the remaining 28 sites was due to
a moderate sensitivity of our method, we performed con-
ventional ChIP assays and detected binding of CTCF to
four of these sites (Figure S2B; Table S3). Since these
known CTCF-binding sites would be considered false
negatives of our method, the sensitivity of our method
was estimated to be about 88% (32 out of 36).
Third, we examined a multiple species sequence align-
ment score (PhastCon) for each CTCF-binding site (Siepel
et al., 2005) to determine their sequence conservation. A
significant fraction (55%, p < 2.2 3 1016) of the CTCF-
binding sites are conserved in vertebrateswith aPhastCon.
Figure 1. Chromosomal Distribution of CTCF-Binding Sites
(A) ChIP-chip analysis results for IGF2/H19 locus are shown.
(B) A view of the CTCF binding at the H19/IGF2 imprint control region is shown.
(C) shows correlation analysis of the number of CTCF-, ER-, and p53-binding sites with gene number on each chromosome.
(D) Correlation analysis of the number of CTCF-, ER-, and p53-binding sites with the length of each chromosome is shown.score of 0.8 or higher (Figure S2C), suggesting that most
CTCF-binding sites identified in our analysis are likely
functional.CDistribution of CTCF-Binding Sites in the Genome
To characterize how the CTCF-binding sites are distrib-
uted along the human genome, we compared theirell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc. 1233
localization to a total of 20,181 well-annotated human
genes (Kent et al., 2002). We performed correlation analy-
sis of CTCF-binding sites with the number of genes or
transcripts found on the chromosomes or with the total
nucleotide length of each chromosome (Figures 1C, 1D,
and S3A). As a control, we examined two enhancer-bind-
ing proteins whose genomic binding sites were recently
determined in human cells: estrogen receptor (ER; Carroll
et al., 2006) and p53 (Wei et al., 2006; Table S4). The re-
sults showed that CTCF binding correlates strongly with
the number of genes on each chromosome (r2 = 0.85),
and the degree of correlation is much higher than both
ER and p53. In contrast, CTCF binding only weakly corre-
lates with the chromosomal length (r2 = 0.42), and the de-
gree of correlation is much less than that of the two tran-
scription activator proteins (Carroll et al., 2006; Figures
1C and 1D). Based on this analysis, we conclude that
the distribution of CTCF-binding sites along the genome
is closely correlated with genes and distinct from other
known sequence-specific transcription factors.
An independent analysis of CTCF localization along
each chromosome also confirmed a strong correlation be-
tween CTCF binding and gene density. We segmented
each chromosome with a sliding 2 Mbp window and cal-
culated the correlation between numbers of CTCF-bind-
ing sites and genes within each window. In general, the
CTCF-binding sites correlate strongly with genes, with
a correlation coefficient of 0.786. In contrast, the average
correlation coefficient between randomly generated ge-
nomic sites and genes is only 0.32 (Figure 2A). The degree
of correlation between the CTCF-binding sites and genes
is similar to that between the TAF1-binding sites, mapped
previously in the same cells, and genes (correlation coef-
ficient of 0.792). This analysis indicates that CTCF binding
is highly restricted to genes, displaying the same property
as a general transcription factor. This property of CTCF
distribution is consistent with its role at insulators and sug-
gests a widespread function of CTCF in the genome.
While the distribution of CTCF-binding sites resembles
that of a general transcription factor such as TAF1, there
are important differences between the two. The majority
of TAF1-binding sites (89%) are within close proximity to
the known 50 ends of transcripts; in contrast, CTCF-bind-
ing sites are generally very far from promoters, with an av-
erage distance of 48,000 bp (Figure 2B). Nearly half (46%)
of the CTCF-binding sites are located in the intergenic re-
gions, consistent with their potential role as insulators.
Only about 20% CTCF sites are near transcription start
sites. Unexpectedly, a significant number of CTCF-bind-
ing sites fall within genes, with 22% in the introns and
12% in the exons (Figure 2C). There is no marked enrich-
ment of CTCF-binding sites near the polyadenylation sites
(Figure S3B). To a large extent the binding of CTCF near
promoters is negatively correlated with gene activity, as
most of these promoters (72%) are not occupied by the
general transcription factor TAF1. This observation is con-
sistent with the possibility that CTCF might function as
a repressor at these promoters. The significance of1234 Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc.CTCF binding within the introns and exons is not clear,
but presumably it might be related to its insulator function
of blocking enhancers and silencers that are present
nearby these sequences. Combined together, these re-
sults demonstrate that CTCF-binding sites are ubiquitous
throughout the genome and display unique distribution
that is distinct from enhancers and promoters.
While CTCF-binding sites are generally correlated with
genes along the entire length of chromosomes, there are
isolated regions that deviate from this trend (Figure 2A).
Two notable types of loci can be defined: one type of
loci is characterized by a relative depletion of CTCF-bind-
ing sites and the other by an enrichment of CTCF-binding
sites. We can define CTCF-depleted loci as those 2 Mbp
windows that exhibit a lower-than-average density of
CTCF-binding sites (less than 2 per 2 Mbp, p < 0.05 for
most chromosomes; Table S5). Likewise, we can define
CTCF-enriched loci as those 2 Mbp windows that exhibit
higher-than-average CTCF-site density (p < 0.001; Table
S6). We observe that the CTCF-depleted domains tend
to include clusters of related gene families and genes that
are transcriptionally coregulated, while CTCF-enriched
domains often have multiple alternative promoters (81%
contain two or more alternative promoters). Both cases
are consistent with the assumption of CTCF-binding sites
acting as insulators.
We have characterized these two types of regions fur-
ther by considering only genes with multiple CTCF-bind-
ing sites or clusters of genes with no CTCF-binding sites.
We have defined 13,766 genomic regions that are flanked
by a pair of consecutive CTCF-binding sites along the ge-
nome and named them CTCF-pair-defined domains
(CPD). About 43% (5969) of CPDs contain at least one
gene locus in its entirety, while the remaining CPDs do
not contain a complete gene. About 74% of all genes in
the genome are surrounded in their entirety by the
CTCF-binding sites. The remaining genes are either telo-
meric to CTCF-binding site (2.6% of genes) or contain in-
ternal CTCF-binding sites (23% of genes). On average,
about 2.5 genes are found in a CPD. The average size of
a CPD is 212,090 bp. A significant number of them (189
CPDs, p < 0.001) contain 9 or more genes, with the largest
one containing as many as 56 genes (p = 3.42 3 1056).
Table 1A lists all CPDs with 15 or more genes (p = 2.2 3
108). These CPDs often correspond to large clusters of
related genes (Sproul et al., 2005), such as the olfactory
receptor (OR) gene clusters (Figure 2D), ZNF gene clus-
ters, KRTAP gene clusters (Figure S4A), type I interferon
(IFN) gene cluster, etcetera.
In contrast to depletion of CTCF-binding sites within
clusters of related genes, there is a significant concentra-
tion of CTCF-binding sites at genes that display extensive
alternative promoter usage. Forty-nine genes contain sig-
nificantly more CTCF-binding sites (eight or more, p =
0.0018; Table 1B) than expected by chance, including
such genes as protocadherin g (pcdhg), T cell receptor
a/d, loci (tcra/d and tcrb), and light-chain l locus (igll; Fig-
ure S4B). These genes all contain a large number of
Figure 2. Distribution of CTCF-Binding Sites Relative to Genes
(A) A chromosomal view of the gene and CTCF-binding-site density of chromosome 11 is shown. Arrows indicate regions within the chromosome
where overall correlation of CTCF-binding sites and gene number deviate from the average.
(B) A histogram summarizing the distribution of CTCF relative to the 50 end of known genes.
(C) A pie chart of CTCF-binding sites mapping to exons, introns, promoters (within 2.5 kb of the start sites), and intergenic regions of the genome is
shown.
(D) shows depletion of CTCF-binding sites at clusters of related genes. A cluster of olfactory receptor (OR) genes is bounded by a pair of CTCF-binding
sites, indicated by a long red vertical lines.
(E) An example of CTCF-binding sites punctuating the alternate promoters in the protocadherin g locus is shown. Red vertical lines indicate CTCF-
binding sites. The blue bars within the top panel show the relative expression of probes that map to the locus. The width of each bar represents the
length of each gene.Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc. 1235
Table 1. Two Distinct Modes of CTCF-Binding-Site Distribution
(A) Gene Clusters Found within CPDs
Coordinates Abbreviation Description # Genes
chr11:48088265-56214717 or olfactory receptors 56
chrX:117723838-128460548 unrelated 41
chr19:19616300-32957396 znf zinc finger protein 32
chr17:36319559-36906400 krtap keratin-associated proteins 30
chr11:4616383-5358451 or olfactory receptors 27
chr1:244426810-245310724 or olfactory receptors 23
chr4:69540367-71551475 ugt2; csn; htn UDP glycosyltransferase 2 family members;
casein alpha, beta, kappa
23
chr11:241380-652375 ifitm interferon-induced transmembrane proteins 22
chrX:139574141-148258030 spanx sperm protein associated with the nucleus
SPANX family proteins
21
chr1:154908208-155781600 cd1 CD1 antigen; olfactory receptors 20
chr16:1484561-1993646 rp ribosomal proteins 20
chr9:122296512-122944407 or olfactory receptors; zinc finger proteins 20
chrX:153148757-153849359 unrelated 20
chr1:149246363-149655393 lce late cornified envelope proteins 19
chr19:59681836-60291665 lilra; kir3dl leukocyte-associated immunoglobulin-like
receptors
19
chr5:140209093-140679714 pcdhb protocadherin beta 19
chrX:150199685-151798057 magea melanoma antigen family A proteins 19
chr12:16404564-21817503 slco solute carrier organic anion transporter family
proteins
18
chr19:48981708-49695890 znf zinc finger proteins 18
chr1:1097984-1346875 tnfrsf tumor necrosis factor receptors 17
chr11:5662785-6228381 or olfactory receptors 17
chr11:59278847-60298781 ms4a membrane-spanning 4-domains 17
chr12:10794287-11530870 tas2r taste receptors 17
chr19:62681155-63092088 znf549 zinc finger proteins 17
chr2:27455959-27838284 unrelated 17
chr21:44755457-45037442 krtap keratin-associated proteins 17
chr8:144686322-145048785 unrelated 17
chrX:100477190-101961011 armcx armadillo repeat-containing proteins 17
chr1:165304985-167371954 sel selectins 16
chr14:37750277-44792052 unrelated 16
chr16:54948373-55293378 mt metallothionein 16
chr19:8625711-9402805 or olfactory receptors 16
chr6:26135302-26312482 hist histones 16
chr6:27868447-27970998 hist histones 16
chr10:73794396-74959208 unrelated 15
chr14:19003935-19843534 or olfactory receptors 15
chr19:41311124-42099100 znf zinc finger proteins 15
chr9:20931328-21385937 ifn interferons 151236 Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc.
Table 1. Continued
(B) Genes with Multiple CTCF-Binding Sites
Coordinates Gene Description # CTCF # Starts
chr22:20777701-21573524 igl lambda immunoglobulin lambda locus 34 30
chr16:68542310-73012791 loc348174 secretory protein LOC348174 29 3
chr22:18830549-20228404 kiaa1666 similar to peripheral-type benzodiazepine
receptor-associated protein 1
27 2
chr1:142300786-145375749 nbpf1 neuroblastoma breakpoint family, member 15 26 2
chr7:71912639-74641641 dkfzp434a0131 DKFZp434A0131 protein isoform 1 25 6
chr7:71884863-74669359 loc541473 FKBP6-like 25 2
chr7:71882976-74679539 trim73 tripartite motif-containing 73 25 2
chr16:14713046-18376428 npip nuclear pore complex interacting protein 24 3
chr16:14835163-18480935 nomo2 NODAL modulator 2 24 3
chr7:71912639-73751143 dkfzp434a0131 DKFZp434A0131 protein isoform 1 20 3
chr17:31517173-33607593 tbc1d3c TBC1 domain family member 3C 20 4
chr10:46077353-49152919 pdzk5b FRMPD2-related 1 20 5
chr15:82659067-83578998 flj22795 similar to cis-Golgi matrix protein GM130 18 2
chr16:14713046-16395314 npip nuclear pore complex interacting protein 17 6
chr17:31517173-33369298 tbc1d3c TBC1 domain family member 3C 17 3
chr1:151647667-151975780 muc1 MUC1 mucin isoform 1 precursor 16 6
chr6:31529509-32034747 rdbp RD RNA-binding protein 16 2
chr7:141638111-142017270 tcrbeta T cell receptor beta 14 2
chr11:130745778-131711925 hnt neurotrimin 14 3
chr5:140690435-140872730 pcdhga1 protocadherin gamma subfamily A 13 46
chr10:78299367-79067583 kcnma1 large conductance calcium-activated
potassium
11 1
chr14:21180948-22090938 tcr alpha/delta T cell receptor alpha locus 11 14
chr11:44537174-44929010 tp53i11 p53-induced protein 11 1
chr12:6304598-6648609 znf384 zinc finger protein 384 11 1alternative promoters, most of which are separated from
each other by CTCF-binding sites (Figure 2E).
In conclusion, CTCF-binding sites are distributed along
the genome in a nonrandom fashion that is different from
the general transcription factors and sequence-specific
activators previously characterized. In one aspect, the
CTCF-binding sites’ distribution is similar to that of a
general transcription factor in that they both closely track
the gene distribution on each chromosome. In com-
parison, the distribution of previously characterized
sequence-specific activators is less strongly correlated
with the gene density but more significantly with chromo-
some length. However, unlike general transcription fac-
tors, which usually associate with the transcription start
sites, the majority of CTCF sites are located remotely
from the promoters. Such a unique property of CTCF
localization is consistent with its putative role as an
insulator-binding protein.CMost In Vivo CTCF-Binding Sites in Putative
Insulators Share a Specific Sequence Motif
Previous studies have implicated divergent and variable
modes of binding by CTCF and have suggested that
CTCF recognizes diverse sequences (Ohlsson et al.,
2001). Identification of a large number of in vivo CTCF-
binding sitesprovides auniqueopportunity tobetter define
the in vivo recognition sequence for this DNA-binding
protein. Using the discriminating matrix enumerator (DME)
algorithm (Smith et al., 2005b), we have identified a motif
that best distinguishes the CTCF-binding sites from their
adjacent, control sequences (Figure 3A). This 20 bp motif
is similar to one particular form of CTCF-binding consen-
sus (Bell and Felsenfeld, 2000) but refines it significantly
in six nucleotide positions (positions 7, 8, 9, 10, 13, and 17;
Figure 3A). This motif is present in over 75% of the experi-
mentally identified CTCF-binding sites but in less than 17%
of the control, surrounding sequences. It is usually locatedell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc. 1237
Figure 3. CTCF-Binding Sites Are Characterized by a 20-Mer Motif
(A) DNA logo (Workman et al., 2005) representing the CTCF-binding motif defined from ChIP-on-chip experiment and the previously reported con-
sensus CTCF-binding sites (Bell and Felsenfeld, 2000) is shown. Height of each letter represents the relative frequency of occurrence of the nucleotide
at each position.
(B) Distribution of high-scoring motifs within the experimentally defined CTCF-binding sites is shown. Yellow horizontal lines represent each CTCF-
binding site, and short blue lines represent the position of a high-scoring 20-mer motif found within the CTCF-binding sites.
(C) EMSA results for 12 CTCF (WT) and the corresponding shuffled (SH) probes (Table S7) shows that 11 of 12 motifs found within the CTCF-binding
sites are specifically recognized by recombinant CTCF protein.in themiddle of theexperimentally identifiedCTCF-binding
fragments, as would be expected if they serve as the point
of contact by the protein in vivo (Figure 3B).
To test if this motif is indeed the CTCF-recognition se-
quence, we performed electrophoretic mobility shift anal-
ysis (EMSA) with 12 randomly selected CTCF-binding
sites. For each binding site, we designed an 80-mer
EMSA probe with the recognizable 20-mer CTCF motif
in the middle (Table S7). We also designed a control probe
by randomly shuffling the 20-mer CTCF motif within each1238 Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc.test sequence. Eleven of the 12 probes were confirmed to
interact specifically with a recombinant CTCF protein in
this assay, while the shuffled probes did not (Figure 3C),
indicating that CTCF indeed recognizes the newly identi-
fied motif. The one probe that failed to interact with
CTCF protein may represent an inferior scoring motif
that is more centrally located but may not correspond to
the true in vivo CTCF-binding site.
From these results, we conclude that under our experi-
mental conditions CTCF binding in vivo appears to be
mediated by a class of similar sequences that is well de-
scribed by a consensus motif. However, a rather signifi-
cant population of in vivo CTCF-binding sites lacks this
motif. Additional analysis has failed to identify any signifi-
cantly overrepresented motifs within these regions. To
test whether these sequences bind directly to CTCF
in vitro, we generated consecutive, overlapping DNA frag-
ments to represent two randomly selected CTCF-binding
sites without the motif (Table S8), and we performed
EMSA. Our results confirm that CTCF can indeed bind to
both sequences in vitro (Figures S5A and S5B). Therefore,
a fraction of the in vivo CTCF-binding sites might have
a distinct binding mode and interact with this protein at
different sequences. Additional experiments are required
to resolve the binding sequence of CTCF at these sites.
The CTCF Motif Is Highly Conserved in Vertebrates
The CTCF protein displays an unusually high conservation
with over 95% amino acid sequence identity within its
DNA-binding domains among all vertebrate homologs.
Moreover, the few amino acid substitutions within the
CTCF DNA-binding domain do not map to any residues
predicted to make direct contacts with the DNA (Pabo
et al., 2001). This high degree of sequence conservation
supports an evolutionarily conserved function for CTCF
and predicts that the CTCF-binding sites should also be
conserved in other vertebrate genomes. Consistent with
this prediction, the 20-mer motif sequence within each
in vivo CTCF-binding site is highly conserved evolution-
arily compared to randomly shuffled motifs (Figure S6).
Furthermore, we have also searched the entire human
genome for the occurrences of CTCF motif, extracted
their aligned sequences in other vertebrate genomes
where sequence information is available, and asked
whether a high-scoring CTCF motif is also present in the
corresponding homologous sequences. To increase the
specificity of computational prediction of CTCF-binding
sites, we have restricted the bases at position 6, 11, 14,
and 16 to the nucleotide that is predominantly present
within the experimentally defined CTCF-binding sites
(see Experimental Procedures for details). A total of
31,905 potential CTCF-binding sites are identified in the
human genome using this method. Of these sites,
19,271 can be aligned to the mouse genome, and 6,553
contained the CTCF consensus motif as defined above.
In contrast, a similar search in the genome with a random
matrix of the same length and base composition identifies
an average of only 149 conserved occurrences, suggest-
ing that the CTCF-binding sequences are highly con-
served (p = 1.27 3 108; Figure 4A). In addition to the
mouse genome, we have examined the conservation of
the predicted human CTCF-binding sequences in other
vertebrate genomes, finding 8,082 (p = 1.19 3 105),
8,154 (p = 3.84 3 106), 6,362 (p = 1.02 3 108), 263
(p = 5.09 3 105), and 204 (p = 5.48 3 105) to be signif-
icantly conserved in dog, cow, rat, chicken, and zebrafish
genomes, respectively (Figure 4A). In total, 12,799 (out of
31,905) computationally predicted CTCF-binding sites inthe human genome are conserved in at least one other
vertebrate genome (excluding the chimp genome; Fig-
ure 4B). We define these highly conserved CTCF-recogni-
tion sequences as potential CTCF-binding sites.
The conserved CTCF-recognition sequences in the hu-
man genome imply that the corresponding motifs in other
species may also function as CTCF-binding sites. To test
this prediction, we have performed EMSA with two pre-
dicted CTCF-binding sites in the chicken genome (Table
S9). The results confirm the binding of CTCF to both
CTCF sites in vitro (Figure 4C).
Most CTCF-Binding Sites Are Occupied in a Different
Cell Type
To evaluate the variability of CTCF binding in a different
cell type, we have performed ChIP-chip analysis to iden-
tify CTCF-binding sites in a hematopoietic progenitor
cell line U937. We have focused our analysis on a set of
44 genomic regions that represent a 1% sampling of the
human genome and are known as the ENCODE regions
(Consortium, 2004; Kim et al., 2005a; ENCODE arrays).
These regions have been semirandomly selected by the
ENCODE consortium as a common platform for genomic
research. We have used the previously described genome
tiling arrays for this experiment (Kim et al., 2005a). These
arrays contain PCR products as probes instead of the ol-
igonucleotides. We have detected 232 sites in U937 cells
at the confidence level of p < 0.000001 (Figures 5A and
5B), which overlap 151 of 225 (67%) CTCF sites detected
within the same regions in IMR90 sites (Figure 5B). Less
restricted criteria result in a larger degree of overlap (Fig-
ure S7). This analysis shows that most of the CTCF-
binding sites detected in IMR90 cells are also occupied
in another cell type, indicating that perhaps most CTCF-
binding sites in the genome are cell-type invariant.
On the other hand, while the overlap between CTCF-
binding sites in U937 and IMR90 cells does increase
with loosened criteria, it does not become 100%. A subset
of the CTCF-binding sites appears to interact with this
protein in a cell-type-dependent manner. To confirm this,
we have performed conventional ChIP assays to test the
binding of CTCF to two IMR90-specific sites and one
U937-specific site (Table S10). The results indicate that
the two IMR90-specific CTCF-binding sites are indeed as-
sociated with the protein in IMR90 cells but not in U937
cells, while a U937-specific CTCF-binding site interacts
with this protein in an opposite way (Figure 5C). We con-
clude that a fraction of the CTCF-binding sites in the ge-
nome may be subject to cell-type-dependent regulation,
although the full extent of this population of CTCF sites re-
mains to be determined.
Evolution of CTCF-Binding Sites in the Vertebrate
Genomes
Sincewewere able to computationally mapCTCF-binding
sites in other vertebrate genomes, we were interested in
knowing how these sites have evolved in different verte-
brate species and whether the changes might reflectCell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc. 1239
Figure 4. CTCF-Recognition Sites Are Highly Conserved in Other Vertebrates
(A) Distribution of CTCF-binding motifs found in other vertebrate genomes is compared to the frequency of a randomly shuffled CTCF motif in each
genome.
(B) Venn diagram of computationally predicted CTCF-binding sites in the human genome that are conserved in other vertebrates is shown. The align-
ments on the right are examples of how each motif with different levels of conservation aligns to the corresponding sequences in other species.
(C) shows EMSA results for two CTCF (WT)-binding sites predicted in the chicken genomes and the corresponding shuffled (SH) probes (Table S9).CTCF function. We have identified 14,352 nucleotide
changes within the 12,799 evolutionarily conserved
CTCF-recognition sequences. Interestingly, the predomi-
nant base substitution occurs at the cytosine at position
16, which happens to be the dominant CG dinucleotide
within the consensus sequence (Figure 6). The cytosine-
to-thymidine transition at this position accounts for nearly
17% of all nucleotide changes. One explanation for the
unusually high rate of C-to-T substitution at this position
is potential DNA methylation at the base (Jones and Bay-
lin, 2002; Rideout et al., 1990), which is consistent with the1240 Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc.regulation of CTCF binding by DNA methylation. This ob-
servation suggests an intriguing evolutionary model of de-
riving differential regulation of genes by simply altering
CTCF binding in the genome, a process that can be facil-
itated by environmental and epigenetic factors.
DISCUSSION
In summary, we have generated a high-resolution map of
CTCF-binding sites in the human genome with unique
distribution and sequence features. This map not only
Figure 5. Comparison of CTCF Binding in Two Cell Types
(A) Representative view of CTCF binding in IMR90 and U937 cells within the ENCODE regions is shown. The first panel lists all known genes within the
region. The second and third panels show the CTCF-binding data within the region for the IMR90 andU937 cells, respectively. The fourth panel shows
the predicted CTCF-binding sites based on 20-mer motif.
(B) A Venn diagram showing the overlap of CTCF binding in IMR90 and U937 cells at the confidence level p < 0.000001.
(C) Validation of three cell-type-specific sites by quantitative real-time PCR (Table S10) is shown. The error bars indicate standard deviation values.confirms most known insulators and CTCF-binding sites
but also identifies over 13,000 novel CTCF-binding se-
quences and potential insulators. Nearly 80% of the
CTCF-binding sites share a consensus motif that is highly
conserved during evolution. We have found that CTCF-
binding sites are largely invariant between cell types.
Our results represent a critical step toward comprehen-
sive identification of CTCF-dependent insulators in the
human genome.
Unique Distribution of CTCF-Binding Sites
in the Human Genome
Unlike sequence-specific transcription activators such as
ER and p53, CTCF-binding sites are ubiquitously and uni-
versally present throughout the genome, and its chromo-
somal distribution is strongly correlated with genes. In this
aspect, CTCF resembles the behavior of general tran-Cscription factors. Yet, locations of CTCF-binding sites
are clearly different from those of general transcription
factors. Except for a relatively small fraction (20%), the
vast majority of CTCF binding occurs at sites remotely
from the transcription start sites (Figure 2B). In contrast,
nearly 90% of the TAF1-binding sites are located at pro-
moters. This unique distribution of CTCF-binding sites in
the genome is consistent with the potential role of these
sequences as insulators.
About half of the CTCF-binding sites are far away from
genes. These distal sites likely define insulators and, in
many cases, coincide with boundaries for gene clusters,
such as OR gene clusters. A number of genes in the mam-
malian genome are arranged into clusters, and the exis-
tence of these clusters has implicated coordinated regula-
tion of expression by shared long-range elements such
as locus control regions, as it is observed for the HoxFigure 6. CTCF-Binding Sites Show
a Unique Nucleotide Change during
Evolution
Nucleotide changes observed within the map-
ped CTCF motifs in all available vertebrate
genomes are shown. Distribution of base
changes observed in the CTCF-binding sites
are plotted along the 20-mer motif.ell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc. 1241
and b-globin gene clusters (Sproul et al., 2005). Recently,
a study showed that the OR gene clusters located on sep-
arated chromosomes share a single enhancer that selec-
tively interacts with only one promoter, resulting in a highly
exclusive activation of a single promoter out of about 1500
others (Lomvardas et al., 2006).
Consistent with this gene-segregation property of
CTCF, the CTCF-binding sites coincide with boundaries
of genes that escaped X inactivation (Filippova et al.,
2005). X inactivation has been shown to involve the estab-
lishment of heterochromatin on one of the two X chromo-
somes of the female genome. A recent study shows that X
inactivation is not uniform along the inactive X chromo-
some (Carrel and Willard, 2005) and identifies a number
of gene clusters that can escape the chromosome-wide
heterochromatin formation. If the CTCF-binding sites in-
deed function as insulators, then one might expect them
to segregate the gene clusters that escape inactivation
on the X chromosome. Indeed, we have observed several
domains on the X chromosome that are surrounded by
CTCF-binding sites (Figure S8).
CTCF-Binding Sites and Selective Usage
of Alternative Promoters
While nearly half of the CTCF-binding sites are found in se-
quences between genes, an equivalent number of CTCF
sites are located within genes. It is not immediately obvi-
ous whether these sequences function as insulators. We
note that many of them appear to segregate alternative
promoters within a single gene and perhaps contribute
to alternative promoter usage. Examples of this are pro-
vided by the protocadherin g locus (PCDHG; Figure 2E),
T cell receptor a/d, b, and g loci (TCRa/d, TCRb, and
TCRg), IgH, and light-chain l locus (IgLk and IgLl;
Figure S4B). In each case, CTCF binding segregates tran-
scriptional start sites that display differential activities
across tissues. About 52% of the human genes possess
multiple promoters. While alternative promoter usage is
very common (Carninci et al., 2005, 2006; Kimura et al.,
2006), the mechanisms are not clearly understood. It is
generally assumed that different promoters employ dis-
tinct regulatory mechanisms to achieve tissue- and tem-
poral-specific activities. The observation that CTCF-bind-
ing sites punctuate alternative promoters may suggest
involvement of insulator elements in the selection of pro-
moters in distinct cell types.
A Consensus Motif Can Explain the Majority
of CTCF-Binding Sites in Possible Insulators
One of the surprising findings of our study is that the vast
majority of the experimentally identified CTCF-binding
sites are characterized by a specific 20-mer motif. We
demonstrate that this motif is highly conserved in verte-
brates and can be used to predict other potential CTCF-
binding sites in the genome. Furthermore, we show that
the newly characterized CTCF consensus sequence spe-
cifically interacts with CTCF protein in vitro. Given the
overwhelming diversity of sequences that CTCF may rec-1242 Cell 128, 1231–1245, March 23, 2007 ª2007 Elsevier Inc.ognize in vitro, our finding of a single dominant CTCF-
binding consensus sequence within the in vivo CTCF-
binding sites is unexpected.
On the other hand, our results do not rule out the exis-
tence of additional CTCF-binding motifs that may be rec-
ognized by the insulator-binding protein along the ge-
nome. As a matter of fact, it is important to note 18% of
the in vivo binding sites do not contain the newly charac-
terized CTCF-binding consensus sequence. When ana-
lyzed in vitro, some of these CTCF-binding sites can
indeed directly interact with CTCF, supporting the exis-
tence of different CTCF-recognition sequences. Further-
more, quite a number of previously characterized CTCF-
binding sequences and insulators lack the newly identified
motif. It is entirely possible that CTCFmay bind to different
classes of DNA sequences, either directly or in association
with a partner. So far, our search has failed to yield another
significant motif among this subset of in vivo CTCF-bind-
ing sites.
In conclusion, we report here the first high-resolution
map of CTCF binding in the human genome, which reveals
several new aspects of CTCF function. Our results provide
a much-needed resource for further investigation of
CTCF’s role in insulator function, imprinting, and long-
range chromosomal interactions.
EXPERIMENTAL PROCEDURES
A detailed description of the experimental methods and materials can
be found in the Supplemental Data. All raw and processed data are
available at http://licr-renlab.ucsd.edu/download.html, the UCSC ge-
nome browser at http://genome.ucsc.edu/, and Gene Expression Om-
nibus at http://www.ncbi.nlm.nih.gov/geo/ (accession #GSE5559).
Monoclonal CTCF antibodies used in this study have been character-
ized and described by E. Pugacheva and coworkers (Pugacheva et al.,
2005) and are available from them upon request.
Chromatin Immunoprecipitation and Microarray Experiments
IMR90 and U937 cells were grown andmaintained according to the di-
rection from American Type Culture Collection. Cells were harvested
and crosslinked with 1% formaldehyde when they reached 80%
confluency on plates. Chromatin immunoprecipitation was performed
as described (Kim et al., 2005b), with the use of 50 ul of equimolar
mixture of nine CTCF monoclonal antibodies and three distinct array
platforms: a whole human genome tiling array (Kim et al., 2005b),
a condensed array which contained a total of 742,156 oligonucleo-
tides, and PCR product arrays covering the ENCODE regions (Kim
et al., 2005a). Microarray data analysis was carried out as described
previously (Kim et al., 2005a, 2005b; see Supplemental Data).
Validation of ChIP-chip Data
Quantitative real-time PCR was performed in duplicate with 0.5 ng of
CTCF ChIP DNA and unenriched total genomic DNA, with iCycler
and SYBR Green iQ Supermix reagent (Bio-Rad Laboratories). Nor-
malized Ct (DCt) values for each sample were calculated by subtract-
ing the Ct value obtained for the unenriched DNA from the Ct value for
the CTCF ChIP DNA (DCt = Ctctcf  Cttotal). The fold enrichment of the
tested promoter sequence in ChIP DNA over the unenriched DNA was
then estimated as described previously (Bernstein et al., 2005; Cawley
et al., 2004). Primers used for this analysis are listed in the Table S1.
Motif Analysis
Motif discovery was performed as described in Smith et al. (2005a,
2005b). All the CTCF-binding sites were used as positive sequences,
and the flanking sequences were used as negative sequences. The
overrepresented sequencemotif found in the positive sequences com-
pared to the negative was selected. Using this sequence motif, we
generated an initial 20 bp position weight matrix (PWM). This 20-mer
PWM was searched against the entire set of CTCF-binding sites,
and all the motifs found in the binding sites were used to generate
the final PWM. The program Stormwas then used to search the human
genome (hg17) for presence of this motif. The high-scoringmotifs were
selected for the presence of key nucleotides C, G, and G and C to-
gether at positions 6, 11, 14, and 16. The resulting CTCF-binding sites
were then mapped to 14 vertebrate genomes using the available lift-
Over and genome-alignment information available from UCSC ge-
nome browser. Each sequence was then scored using Storm and fil-
tered for the critical nucleotides as per the human genome scan.
EMSA
EMSA was carried out as described (Pugacheva et al., 2005). Briefly,
the DNA-binding domain of CTCF (11-ZF) and luciferase (Luc) were
in vitro synthesized from pET-11ZF and T7 control plasmids, respec-
tively (Awad et al., 1999; Filippova et al., 1996), by using TnT T7 Quick
Coupled Transcription/Translation System (Promega, Madison, WI,
Cat.# L1170). DNA fragments (Table S2) were end-labeled at their 50
ends using 32P-g-ATP and T4 polynucleotide kinase. The labeled
DNAwas gel purified, combinedwith equal amounts of in-vitro-synthe-
sized protein, and incubated for 30 min at room temperature followed
by electrophoresis on 5% nondenaturing polyacrylamide gels.
Analysis of Statistical Significance
Statistical significance of the computationally mapped CTCF sites was
analyzed by comparing the number of mapped sites to the distribution
of the number of sites mapped using randommotif resulting from 1000
iterations. The random PWM was derived from randomizing the posi-
tion within the 20-mer CTCF motif. Statistical significance of observed
gene clusters within CPDs and multiple CTCF-binding sites within
a gene was analyzed by calculating the expected probability of each
number of observed genes per CPD or each number of CTCF-binding
sites per gene using Poisson distribution function. Statistical signifi-
cance of observed evolutionary conservation of CTCF-binding sites
compared to random sites was analyzed by Mann-Whitney-Wilcoxon
test.
Supplemental Data
Supplemental Data include eight figures, ten tables, experimental pro-
cedures, and references and can be found with this article online at
http://www.cell.com/cgi/content/full/128/6/1231/DC1/.
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